Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8250)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2017 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu ZJ, Wu JJ, Jiang WL, Xiao JH, Tao KZ, Ma L, Zheng P, Wan R, Wang XP. MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression. World J Gastroenterol 2017; 23(6): 976-985 [PMID: 28246471 DOI: 10.3748/wjg.v23.i6.976] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i6/976.htm |
| Number | Citing Articles |
| 1 |
Marco Bocchetti, Maria Grazia Ferraro, Filippo Ricciardiello, Alessandro Ottaiano, Amalia Luce, Alessia Maria Cossu, Marianna Scrima, Wing-Yan Leung, Marianna Abate, Paola Stiuso, Michele Caraglia, Silvia Zappavigna, Tung On Yau. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(8): 3967 doi: 10.3390/ijms22083967
|
| 2 |
Peter Dobranowski, Laura M Sly. SHIP negatively regulates type II immune responses in mast cells and macrophages. Journal of Leukocyte Biology 2018; 103(6): 1053 doi: 10.1002/JLB.3MIR0817-340R
|
| 3 |
Alba Rodríguez-Nogales, Francesca Algieri, José Garrido-Mesa, Teresa Vezza, Maria P. Utrilla, Natalia Chueca, Jose A. Fernández-Caballero, Federico García, Maria E. Rodríguez-Cabezas, Julio Gálvez. The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00468
|
| 4 |
Soheila Moein, Mostafa Vaghari‐Tabari, Durdi Qujeq, Maryam Majidinia, Seyed Mohammad Nabavi, Bahman Yousefi. MiRNAs and inflammatory bowel disease: An interesting new story. Journal of Cellular Physiology 2019; 234(4): 3277 doi: 10.1002/jcp.27173
|
| 5 |
Ziling Zhong, Xueying Huang, Shaojie Zhang, Shaochuan Zheng, Xiqiao Cheng, Rongrong Li, Di Wu, Liping Mo, Shenhong Qu. Blocking Notch signalling reverses miR-155-mediated inflammation in allergic rhinitis. International Immunopharmacology 2023; 116: 109832 doi: 10.1016/j.intimp.2023.109832
|
| 6 |
Shaho Khayati, Sajad Dehnavi, Mahvash Sadeghi, Jalil Tavakol Afshari, Seyed-Alireza Esmaeili, Mojgan Mohammadi. The potential role of miRNA in regulating macrophage polarization. Heliyon 2023; 9(11): e21615 doi: 10.1016/j.heliyon.2023.e21615
|
| 7 |
Pauline Floch, Caroline Capdevielle, Cathy Staedel, Julien Izotte, Elodie Sifré, Amandine M. Laur, Alban Giese, Victoria Korolik, Pierre Dubus, Francis Mégraud, Philippe Lehours. Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection. Frontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00185
|
| 8 |
Matthias Hübenthal, Andre Franke, Simone Lipinski, Simonas Juzėnas. Molecular Genetics of Inflammatory Bowel Disease. 2019; : 203 doi: 10.1007/978-3-030-28703-0_10
|
| 9 |
Sergiu Pasca, Ancuta Jurj, Bobe Petrushev, Ciprian Tomuleasa, Daniela Matei. MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00625
|
| 10 |
Kristina Johansson, Julie Weidner, Madeleine Rådinger. MicroRNAs in type 2 immunity. Cancer Letters 2018; 425: 116 doi: 10.1016/j.canlet.2018.03.036
|
| 11 |
Melissa Pergande, Antony Cougnoux, Rathnayake Rathnayake, Forbes Porter, Stephanie Cologna. Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model. Molecules 2019; 24(5): 994 doi: 10.3390/molecules24050994
|
| 12 |
Ioanna Aggeletopoulou, Athanasia Mouzaki, Konstantinos Thomopoulos, Christos Triantos. miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?. International Journal of Molecular Sciences 2023; 24(3): 2233 doi: 10.3390/ijms24032233
|
| 13 |
Zixue Cheng, Nan L. Xia, Ziyan Chen, Mei Li, Zhicheng Tang, Haolin Wu, Xinyi Yan, Yue Wang, Yuchun Wang, Xiaojun Tang, Huayong Zhang, Lingyun Sun. SHIP1 is required for the formation of neutrophil extracellular traps in rheumatoid arthritis. International Immunopharmacology 2023; 115: 109625 doi: 10.1016/j.intimp.2022.109625
|
| 14 |
Thais Gagno Grillo, Ana Elisa Valencise Quaglio, Rodrigo Fedatto Beraldo, Talles Bazeia Lima, Julio Pinheiro Baima, Luiz Claudio Di Stasi, Ligia Yukie Sassaki. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World Journal of Gastrointestinal Oncology 2021; 13(9): 995-1016 doi: 10.4251/wjgo.v13.i9.995
|
| 15 |
Carolina Battistini, Rafael Ballan, Marcos Edgar Herkenhoff, Susana Marta Isay Saad, Jun Sun. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2020; 22(1): 362 doi: 10.3390/ijms22010362
|
| 16 |
Qiyu Qin, Yi Wang, Xiaodan Huang, Xiuming Jin. SHIP-1 affects herpetic simplex keratitis prognosis by mediating CD4+ T lymphocytes migration through PI3K signaling and transcription factor KLF2 in the cornea. Antiviral Research 2022; 207: 105424 doi: 10.1016/j.antiviral.2022.105424
|
| 17 |
E.G. De Smet, H.P. Van Eeckhoutte, F. Avila Cobos, E. Blomme, F.M. Verhamme, S. Provoost, S.E. Verleden, K. Venken, T. Maes, G.F. Joos, P. Mestdagh, G.G. Brusselle, K.R. Bracke. The role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD. Mucosal Immunology 2020; 13(3): 423 doi: 10.1038/s41385-019-0241-6
|
| 18 |
Artin Soroosh, Marina Koutsioumpa, Charalabos Pothoulakis, Dimitrios Iliopoulos. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(2): G256 doi: 10.1152/ajpgi.00268.2017
|
| 19 |
Zhen Zeng, Arjudeb Mukherjee, Hu Zhang. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01017
|
| 20 |
Natalia Diaz-Garrido, Cecilia Cordero, Yenifer Olivo-Martinez, Josefa Badia, Laura Baldomà. Cell-to-Cell Communication by Host-Released Extracellular Vesicles in the Gut: Implications in Health and Disease. International Journal of Molecular Sciences 2021; 22(4): 2213 doi: 10.3390/ijms22042213
|
| 21 |
Yingming Fei, Zhiwei Wang, Minmin Huang, Xinjuan Wu, Fangqin Hu, Jinlong Zhu, Youlin Yu, Huajiang Shen, Yong Wu, Guilin Xie, Zumo Zhou. MiR‐155 regulates M2 polarization of hepatitis B virus‐infected tumour‐associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma. Journal of Viral Hepatitis 2023; 30(5): 417 doi: 10.1111/jvh.13809
|
| 22 |
Mikkel Malham, Jaslin P. James, Christian Jakobsen, Estrid Hoegdall, Kim Holmstroem, Vibeke Wewer, Boye S. Nielsen, Lene B. Riis. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis. Aging 2021; 13(5): 6359 doi: 10.18632/aging.202715
|
| 23 |
Margaret L. Hibbs, April L. Raftery, Evelyn Tsantikos. Regulation of hematopoietic cell signaling by SHIP-1 inositol phosphatase: growth factors and beyond. Growth Factors 2018; 36(5-6): 213 doi: 10.1080/08977194.2019.1569649
|
| 24 |
Jiang Xin. Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges. Digestive and Liver Disease 2023; 55(2): 169 doi: 10.1016/j.dld.2022.08.012
|
| 25 |
Jaslin P. James, Lene Buhl Riis, Mikkel Malham, Estrid Høgdall, Ebbe Langholz, Boye S Nielsen. MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer. International Journal of Molecular Sciences 2020; 21(21): 7893 doi: 10.3390/ijms21217893
|
| 26 |
Baishun Li, Liyang Guo, Ying He, Xinran Tu, Jialin Zhong, Hongbing Guan, Yiguo Jiang, Qianzhou Jiang. MicroRNA-155 expression is associated with pulpitis progression by targeting SHIP1. Molecular Biology Reports 2022; 49(9): 8575 doi: 10.1007/s11033-022-07690-w
|
| 27 |
Shiyuan Wang, Yan Huang, Cili Zhou, Huangan Wu, Jimeng Zhao, Luyi Wu, Min Zhao, Fang Zhang, Huirong Liu. The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/7565076
|
| 28 |
Arjun Saradna, Danh C. Do, Shruthi Kumar, Qing-Ling Fu, Peisong Gao. Macrophage polarization and allergic asthma. Translational Research 2018; 191: 1 doi: 10.1016/j.trsl.2017.09.002
|
| 29 |
Lingyan Ma, Chenyang Hou, Hua Yang, Qu Chen, Wentao Lyu, Zhen Wang, Jianfeng Wang, Yingping Xiao. Multi-omics analysis reveals the interaction of gut microbiome and host microRNAs in ulcerative colitis. Annals of Medicine 2023; 55(2) doi: 10.1080/07853890.2023.2261477
|
| 30 |
Charlotte Nejad, H. James Stunden, Michael P. Gantier. A guide to miRNAs in inflammation and innate immune responses. The FEBS Journal 2018; 285(20): 3695 doi: 10.1111/febs.14482
|
| 31 |
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Negar Ghanaatian, Parichehr Kohansal, Mohammad Hosein Farzaei, Khashayar Afshari, Amirhossein Sahebkar, Amir Hossein Abdolghaffari. Targeting Mammalian Target of Rapamycin: Prospects for the Treatment of Inflammatory Bowel Diseases. Current Medicinal Chemistry 2021; 28(8): 1605 doi: 10.2174/0929867327666200504081503
|
| 32 |
Jianting Shi, Ming Chen, Lihua Ouyang, Qiujie Wang, Yimin Guo, Linjie Huang, Shanping Jiang. miR‐142‐5p and miR‐130a‐3p regulate pulmonary macrophage polarization and asthma airway remodeling. Immunology & Cell Biology 2020; 98(9): 715 doi: 10.1111/imcb.12369
|
| 33 |
Neha Datta, Charlotte Johnson, Dina Kao, Pratik Gurnani, Cameron Alexander, Christos Polytarchou, Tanya M. Monaghan. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacological Research 2023; 194: 106870 doi: 10.1016/j.phrs.2023.106870
|
| 34 |
Charalampia Amerikanou, Efstathia Papada, Aristea Gioxari, Ilias Smyrnioudis, Stamatia-Angeliki Kleftaki, Evdokia Valsamidou, Victoria Bruns, Rajarshi Banerjee, Maria Giovanna Trivella, Natasa Milic, Milica Medić-Stojanoska, Amalia Gastaldelli, Aimo Kannt, George V. Dedoussis, Andriana C. Kaliora. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. Pharmacological Research 2021; 171: 105753 doi: 10.1016/j.phrs.2021.105753
|
| 35 |
Wang-Dong Xu, Si-Yu Feng, An-Fang Huang. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review. Inflammation Research 2022; 71(12): 1501 doi: 10.1007/s00011-022-01643-6
|
| 36 |
Shulan Qu, Yunhui Shen, Mengjie Wang, Xiaoyu Wang, Yifu Yang. Suppression of miR-21 and miR-155 of macrophage by cinnamaldehyde ameliorates ulcerative colitis. International Immunopharmacology 2019; 67: 22 doi: 10.1016/j.intimp.2018.11.045
|
| 37 |
Maite Casado-Bedmar, Emilie Viennois. MicroRNA and Gut Microbiota: Tiny but Mighty—Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics. Journal of Crohn's and Colitis 2022; 16(6): 992 doi: 10.1093/ecco-jcc/jjab223
|
| 38 |
Letizia Masi, Ivan Capobianco, Carlotta Magrì, Irene Marafini, Valentina Petito, Franco Scaldaferri. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(14): 7991 doi: 10.3390/ijms23147991
|
| 39 |
Penghui Li, Di Huang, Xinyu Gu. Exploring the dual role of circRNA and PI3K/AKT pathway in tumors of the digestive system. Biomedicine & Pharmacotherapy 2023; 168: 115694 doi: 10.1016/j.biopha.2023.115694
|
| 40 |
Jie Guo, Mengfan Liao, Jun Wang. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00771-6
|
| 41 |
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, Andrea Galli, Gabriele Dragoni. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?. Inflammatory Bowel Diseases 2023; 29(2): 308 doi: 10.1093/ibd/izac122
|
| 42 |
Dexi Zhou, Kui Yang, Lu Chen, Wen Zhang, Zhenyu Xu, Jian Zuo, Hui Jiang, Jiajie Luan. Promising landscape for regulating macrophage polarization: epigenetic viewpoint. Oncotarget 2017; 8(34): 57693 doi: 10.18632/oncotarget.17027
|
| 43 |
P. N. Alexandrov, M. E. Percy, Walter J. Lukiw. Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down’s Syndrome and Trisomy-21 Linked Disease. Cellular and Molecular Neurobiology 2018; 38(3): 769 doi: 10.1007/s10571-017-0514-0
|
| 44 |
Kittipong Maneechotesuwan. Role of microRNA in severe asthma. Respiratory Investigation 2019; 57(1): 9 doi: 10.1016/j.resinv.2018.10.005
|
| 45 |
Leandro Encarnação Garcia, Erivelto Corrêa de Araújo Junior, Larissa Martins Melo, Jaqueline Poleto Bragato, Juliana Regina Peiró, Valéria Marçal Félix de Lima, Márcia Marinho, Daniel Robert Arnold, Flavia Lombardi Lopes, Dhafer Laouini. Characterization of the microtranscriptome of macrophages infected with virulent, attenuated and saprophyte strains of Leptospira spp.. PLOS Neglected Tropical Diseases 2018; 12(7): e0006621 doi: 10.1371/journal.pntd.0006621
|